However, MYC is not the only HSP90 client protein in Burkitt lymphoma, and so it is possible that the mechanism of action is not exclusively through MYC, but involves the destabilization of cell cycle regulators such as CDK2 and CDK4 directly due to loss of HSP90 function. The gene discussed is CDK2; the disease is Burkitt lymphoma.